Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

319 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Patient-reported outcomes 12 months after hepatitis C treatment with direct-acting antivirals: Results from the PROP UP study.
Serper M, Evon DM, Amador J, Stewart PW, Sarkar S, Lok AS, Sterling RK, Reeve BB, Golin CE, Rajender Reddy K, Lim JK, Reau N, Nelson DR, Di Bisceglie AM, Fried MW. Serper M, et al. Among authors: sterling rk. Liver Int. 2021 Apr;41(4):692-704. doi: 10.1111/liv.14781. Epub 2021 Jan 22. Liver Int. 2021. PMID: 33387381 Free PMC article.
Treatment of chronic hepatitis C in patients who failed interferon monotherapy: effects of higher doses of interferon and ribavirin combination therapy. The Virginia Cooperative Hepatitis Treatment Group.
Shiffman ML, Hofmann CM, Gabbay J, Luketic VA, Sterling RK, Sanyal AJ, Contos MJ, Ryan MJ, Yoshida C, Rustgi V. Shiffman ML, et al. Among authors: sterling rk. Am J Gastroenterol. 2000 Oct;95(10):2928-35. doi: 10.1111/j.1572-0241.2000.02321.x. Am J Gastroenterol. 2000. PMID: 11051370 Clinical Trial.
A multicenter, randomized trial of daily high-dose interferon-alfa 2b for the treatment of chronic hepatitis c: pretreatment stratification by viral burden and genotype.
Fried MW, Shiffman M, Sterling RK, Weinstein J, Crippin J, Garcia G, Wright TL, Conjeevaram H, Reddy KR, Peter J, Cotsonis GA, Nolte FS. Fried MW, et al. Among authors: sterling rk. Am J Gastroenterol. 2000 Nov;95(11):3225-9. doi: 10.1111/j.1572-0241.2000.03433.x. Am J Gastroenterol. 2000. PMID: 11095346 Clinical Trial.
Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C.
Bonkovsky HL, Naishadham D, Lambrecht RW, Chung RT, Hoefs JC, Nash SR, Rogers TE, Banner BF, Sterling RK, Donovan JA, Fontana RJ, Di Bisceglie AM, Ghany MG, Morishima C; HALT-C Trial Group. Bonkovsky HL, et al. Among authors: sterling rk. Gastroenterology. 2006 Nov;131(5):1440-51. doi: 10.1053/j.gastro.2006.08.036. Epub 2006 Aug 18. Gastroenterology. 2006. PMID: 17101320 Clinical Trial.
Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis.
Bonkovsky HL, Snow KK, Malet PF, Back-Madruga C, Fontana RJ, Sterling RK, Kulig CC, Di Bisceglie AM, Morgan TR, Dienstag JL, Ghany MG, Gretch DR; HALT-C Trial Group. Bonkovsky HL, et al. Among authors: sterling rk. J Hepatol. 2007 Mar;46(3):420-31. doi: 10.1016/j.jhep.2006.10.009. Epub 2006 Nov 27. J Hepatol. 2007. PMID: 17196293 Free PMC article. Clinical Trial.
319 results